Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Investigator Initiated Study: Galantamine CR Potential Enhancement of Attentional and Executive Function in Non-Demented Patients With Parkinson's Disease

NCT00211588 is registered in ClinicalTrials.gov with Memorial Hospital of Rhode Island as lead sponsor.

NCT NCT00211588
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00211588 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Investigator Initiated Study: Galantamine CR Potential Enhancement of Attentional and Executive Function in Non-Demented Patients With Parkinson's Disease
Lead sponsor
Memorial Hospital of Rhode Island
Phase
Not applicable
Overall status
Unknown status
Start date
June 30, 2004
Completion date
May 31, 2007
Enrollment
90 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

parkinson's disease